Supernus Pharmaceuticals, Inc. insider trading
This tab shows only the shares insiders bought or sold on the open market in the last twelve months (Form 4 codes P and S). Grants, option exercises, shares held back for tax and gifts are left out on purpose, so what is left is insiders trading at the market price like anyone else.
In the last twelve months insiders at Supernus Pharmaceuticals, Inc. filed 20 open-market sales worth $10.3 million and 0 open-market purchases, on Form 4 with the SEC. The latest: Bhatt Padmanabh P., Sr. VP of IP, CSO, sold 6,838 shares at $49.55 on 18 March 2026, filed 18 March 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 18 March 2026 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sale | 6,838 | $49.55 | $338,823 | Form 4 |
| 18 March 2026 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sale | 412 | $50.48 | $20,798 | Form 4 |
| 17 March 2026 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sale | 27,710 | $49.95 | $1.4 million | Form 4 |
| 17 March 2026 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sale | 22,290 | $50.73 | $1.1 million | Form 4 |
| 16 March 2026 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sale | 34,114 | $50.18 | $1.7 million | Form 4 |
| 16 March 2026 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sale | 15,886 | $50.49 | $802,084 | Form 4 |
| 13 March 2026 | Khattar Jack A. | President, CEO | Sale | 24,138 | $50.09 | $1.2 million | Form 4 |
| 13 March 2026 | Khattar Jack A. | President, CEO | Sale | 10,742 | $51.00 | $547,842 | Form 4 |
| 13 March 2026 | Khattar Jack A. | President, CEO | Sale | 120 | $51.75 | $6,210 | Form 4 |
| 12 March 2026 | Hudson Frederick M. | Director | Sale | 5,369 | $50.61 | $271,725 | Form 4 |
| 10 March 2026 | Horich William Todd | SVP, Commercial Operations | Sale | 4,439 | $55.00 | $244,145 | Form 4 |
| 9 March 2026 | Mottola Frank | SVP, Chief Tech. Ops. Officer | Sale | 1,623 | $53.65 | $87,074 | Form 4 |
| 9 March 2026 | Horich William Todd | SVP, Commercial Operations | Sale | 4,438 | $54.00 | $239,652 | Form 4 |
| 6 March 2026 | Gemayel Georges | Director | Sale | 8,787 | $53.00 | $465,711 | Form 4 |
| 5 March 2026 | Gemayel Georges | Director | Sale | 10,000 | $53.71 | $537,100 | Form 4 |
| 19 February 2026 | Sensenig Bethany | Director | Sale | 1,217 | $50.31 | $61,227 | Form 4 |
| 19 February 2026 | Sensenig Bethany | Director | Sale | 3,258 | $51.27 | $167,038 | Form 4 |
| 19 December 2025 | Mottola Frank | SVP, Chief Tech. Ops. Officer | Sale | 5,000 | $50.22 | $251,100 | Form 4 |
| 19 December 2025 | Mottola Frank | SVP, Chief Tech. Ops. Officer | Sale | 15,000 | $50.47 | $757,050 | Form 4 |
| 18 December 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sale | 710 | $44.44 | $31,552 | Form 4 |
A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Supernus Pharmaceuticals, Inc.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.